Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study
2018
Introduction
Tumor profiling by targeted next-generation sequencing (tNGS) and personalized treatment based on these results is becoming increasingly common in patients with metastatic solid tumors, but it remains unclear whether this strategy results in benefit to patients with metastatic prostate cancer (mPCa).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
18
References
9
Citations
NaN
KQI